Segal Niv
Transaction: 03/18/2026
OTHER
Change
0
Price
Not reported
Filing
03/23/2026
Type
OTHER
XTL Biopharmaceuticals Ltd.
XTLB • Biotechnology
$1.90
▼ -0.04 (-2.06%)
Current price
EarningsLatest report: Dec 31, 2024
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$209,047.5
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.03Weak liquidity · 0.61Weak profitability
Financial data as of: Dec 31, 2024, 12:00 AM UTCLast earnings update: Jan 1, 2025, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.90
Change-2.06%
Shares Out110.03K
Market Cap$209.05K
Enterprise Value$-795.95K
52W Range2.01 - 10.28
Beta0.56
P/E-0.20
P/S0.46
P/B0.04
EV/Sales-1.76
EV/EBITDA1.01
Price$1.90
Change-2.06%
Shares Out110.03K
Market Cap$209.05K
Enterprise Value$-795.95K
52W Range2.01 - 10.28
Beta0.56
P/E-0.20
P/S0.46
P/B0.04
EV/Sales-1.76
EV/EBITDA1.01
Earnings Yield-491.28%
FCF Yield0.00%
Dividend Yield0.00%
Gross Margin0.67%
Oper. Margin-4.82%
Profit Margin-2.28%
Debt/Eq0.03
Current Ratio0.61
Quick Ratio0.61
Volume94.70K
Avg Volume1.92M
EPS Surprise-0.15
Investment DNA
How strong this company looks for long-term investors
43
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
39/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
91/100
Why this score▼
Manageable debt level · 0.03Weak liquidity · 0.61Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 2 analyst votes · 2026-10-20
100/100
Bullish
Bullish
2
Hold
0
Bearish
0
Insider Transactions
Recent executive and insider activity
⚠ 6 high-volume insider sells detected
Hillel Fain Osnat
Transaction: 03/18/2026
OTHER
Change
+1,000,000
Price
$0.01
Filing
03/23/2026
Type
OTHER
EDELMAN JOSEPH
Transaction: 11/19/2008
SELL
Change
-9,600,000
Price
$0.15
Filing
12/03/2008
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Segal Niv | OTHER | 0 | Not reported | 03/18/2026 | 03/23/2026 |
| Hillel Fain Osnat | OTHER | +1,000,000 | $0.01 | 03/18/2026 | 03/23/2026 |
| EDELMAN JOSEPH | SELL | -9,600,000 | $0.15 | 11/19/2008 | 12/03/2008 |
| EDELMAN JOSEPH | SELL | -299,570 | $0.15 | 11/18/2008 | 12/03/2008 |
| GOOD JENNIFER L | SELL | -300,000 | $0.20 | 11/10/2008 | 11/04/2008 |
| Rudman Samuel | SELL | -300,000 | $0.20 | 11/10/2008 | 11/04/2008 |
| ZUERBLIS KENNETH J | SELL | -300,000 | $0.20 | 11/10/2008 | 11/04/2008 |
| WEISS MICHAEL S | BUY | +3,500,000 | $0.20 | 10/10/2008 | 11/04/2008 |
| WEINER BEN-ZION | BUY | +300,000 | $0.20 | 10/10/2008 | 11/04/2008 |
| WEISS MICHAEL S | SELL | -3,083,333 | $0.36 | 12/30/2007 | 11/04/2008 |
| KENNEDY WILLIAM JAMES | SELL | -20,000 | $0.20 | 08/01/2005 | 11/04/2008 |
| WEINER BEN-ZION | SELL | 0 | Not reported | 08/27/2008 | 09/04/2008 |
| WEINER BEN-ZION | SELL | 0 | Not reported | 08/27/2008 | 09/04/2008 |
| WEISS MICHAEL S | SELL | 0 | Not reported | 08/22/2008 | 08/26/2008 |
| WEISS MICHAEL S | SELL | 0 | Not reported | 08/22/2008 | 08/26/2008 |
| EDELMAN JOSEPH | BUY | +2,040 | $3.23 | 06/10/2008 | 06/19/2008 |
| EDELMAN JOSEPH | BUY | +1,340 | $3.36 | 06/09/2008 | 06/11/2008 |
| EDELMAN JOSEPH | BUY | +4,000 | $3.43 | 06/06/2008 | 06/11/2008 |
| EDELMAN JOSEPH | BUY | +96,000 | $3.37 | 06/05/2008 | 06/11/2008 |
| EDELMAN JOSEPH | BUY | +4,000 | $3.37 | 06/05/2008 | 06/11/2008 |